MedTrace Logo

Antenatal Platelet Response on Aspirin: a Pharmacokinetic Study Through Pregnancy

NCT04645004 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-04-18

No results posted yet for this study

Summary

Longitudinal pharmacokinetic and pharmacodynamic study in first and third trimester of pregnancy

Conditions

Interventions

DRUG

Aspirin 81Mg Non-enteric coated Tab

one tab daily

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • March of Dimes

    collaborator OTHER

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Rupsa C Boelig, MD · Thomas Jefferson University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-29
Primary Completion
2024-01-11
Completion
2024-03-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04645004 on ClinicalTrials.gov